The gut and intestinal bacteria in chronic heart failure

Anja Sandek, Stefan D. Anker, Stephan von Haehling

Research output: Contribution to journalArticlepeer-review

Abstract

Chronic heart failure (CHF) is now recognized as a multisystem disorder with increased sympathetic tone, hormonal derangements, an anabolic/ catabolic imbalance, endothelial dysfunction, and systemic low-grade inflammation affecting various organ systems. Pro-inflammatory cytokines appear to play important roles in that context. There is increasing evidence for the gut to have a pathophysiological role for both chronic inflammation and malnutrition in CHF. Indeed, disturbed intestinal microcirculation and barrier function in CHF seem to trigger cytokine generation, thereby contributing to further impairment in cardiac function. On the other hand, myocardial dysfunction can induce microcirculatory injuries leading to a disruption in the intestinal barrier. This amplifies the inflammatory response. Furthermore, alterations of specific absorption functions of the intestinal mucosa in CHF may aggravate symptoms of cachexia. The increased number of adherent bacteria seen in patients with CHF and elevated systemic levels of anti-lipopolysaccharide immunoglobulin A underscore this fact. Therefore, the gut poses an interesting target for therapeutic interventions in patients with CHF.

Original languageEnglish
Pages (from-to)22-28
Number of pages7
JournalCurrent Drug Metabolism
Volume10
Issue number1
DOIs
Publication statusPublished - 2009

Keywords

  • Antibodies
  • Cachexia
  • Chronic heart failure
  • Cytokines
  • Gut
  • Inflammation
  • Intestinal dysfunction

ASJC Scopus subject areas

  • Pharmacology
  • Clinical Biochemistry

Fingerprint Dive into the research topics of 'The gut and intestinal bacteria in chronic heart failure'. Together they form a unique fingerprint.

Cite this